Table 1 Summary of studies in the present review
References | Indication | No. of patients | Lesion size (mm), median (range) | Technical success rate (%) | Complications | R0 rate (%) |
|---|---|---|---|---|---|---|
Fahndrich et al. [10] | NET | 1 | 20 | 100(1/1) | No | 100 (1/1) |
Schmidt et al. [11] | SMT (2), Nonlifting adenoma (2) | 4 | SMT, 16 (10-22) Adenoma, 22.5 (15-30) | 100 (4/4) | Minor bleeding in 2 patients | 75 (3/4) |
Milano et al. [16] | NET | 1 | 10 | 100 (1/1) | No | 100 (1/1) |
Sarker et al. [15] | SMT | 3 | 11.3 (9-15) | 100 (3/3) | No | 100 (3/3) |
Al-Bawardy et al. [12] | SMT | 3 | 9.3 (5-15) | 100 (3/3) | No | 100 (3/3) |
Schempf et al. [14] | R1-margins of NET (G1) | 1 | 15 | 100 (1/1) | No | 100 (1/1) |
Andrisani et al. [13] | Nonlifting sign, SMT, Adenoma recurrence | 4 | 14.3 (10-20) | 100 (4/4) | No | 75 (3/4) |
Nassri et al. [17] | NET | 1 | 10 | 100 (1/1) | No | 100 (1/1) |
Tashima et al. [18] | NET | 13 | 6 (3-8) | 100 (14/14) | No | 92.9 (13/14) |